Viewing Study NCT04036461


Ignite Creation Date: 2025-12-24 @ 12:47 PM
Ignite Modification Date: 2026-01-05 @ 12:39 AM
Study NCT ID: NCT04036461
Status: TERMINATED
Last Update Posted: 2024-08-30
First Post: 2019-07-25
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of CC-99712, a BCMA Antibody-Drug Conjugate, in Participants With Relapsed and Refractory Multiple Myeloma
Sponsor: Celgene
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: CC-99712-MM-001
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators